SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001493152-23-037977 from Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)

Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)
Date: Oct. 23, 2023 · CIK: 0001106838 · Accession: 0001493152-23-037977

AI Filing Summary & Sentiment

File numbers found in text: 333-274581

Date
October 24, 2023
Author
Chief
Form
CORRESP
Company
Sonnet BioTherapeutics Holdings, Inc. (SONN) (CIK 0001106838)

Letter

Re: Sonnet BioTherapeutics Holdings, Inc. (the “Company”)

October 23, 2023

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

F Street, N.E.

Washington, D.C. 20549

Registration Statement on Form S-1 (File No. 333-274581)

Ladies and Gentlemen:

In accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission at 4:30 p.m., Eastern Time, on October 24, 2023, or as soon as practicable thereafter.

Please call Tracy F. Buffer of Lowenstein Sandler LLP at 973-597-2434 to confirm the effectiveness of the Registration Statement or with any questions.

Very
truly yours,
SONNET
BIOTHERAPEUTICS HOLDINGS, INC.

Show Raw Text
CORRESP
1
filename1.htm

October
23, 2023

VIA
EDGAR

United
States Securities and Exchange Commission

Division
of Corporation Finance

100
F Street, N.E.

Washington,
D.C. 20549

    Re:
    Sonnet
    BioTherapeutics Holdings, Inc. (the “Company”)

    Registration
    Statement on Form S-1 (File No. 333-274581)

Ladies
and Gentlemen:

In
accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the above-referenced Registration
Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission at 4:30 p.m.,
Eastern Time, on October 24, 2023, or as soon as practicable thereafter.

Please
call Tracy F. Buffer of Lowenstein Sandler LLP at 973-597-2434 to confirm the effectiveness of the Registration Statement or with any
questions.

    Very
    truly yours,

    SONNET
    BIOTHERAPEUTICS HOLDINGS, INC.

    By:
    /s/
    Pankaj Mohan

    Name:
    Pankaj
    Mohan

    Title:
    Chief
    Executive Officer